Target intelligence / Profile preview

Azurin

Molecular classification
Electron transfer protein, Type 1 (blue) copper protein, Cupredoxin superfamily, Metalloprotein
01

Overview

Azurin is a small (~14 kDa) blue copper-containing electron transfer protein found in the periplasm of gram-negative bacteria, particularly *Pseudomonas aeruginosa*. Structurally, it is a monomer with a beta-barrel configuration stabilized by a copper ion coordinated by conserved amino acids[1][2][6][8]. Its classic biological role is to moderate single-electron transfer by cycling between Cu(I) and Cu(II) oxidation states during cellular respiration. Beyond its electron transfer function, azurin exhibits preferential cytotoxicity toward a variety of human cancer cells by entering these cells, binding to the tumor suppressor protein p53, and promoting apoptosis, while sparing most normal cells[3]. The internal p28 domain of azurin enables cell penetration and is being investigated as an anticancer peptide. Additional studies revealed that azurin can interfere with ephrinB2-mediated signaling in cancer cells, further supporting its potential as an antitumor agent. While not a receptor, enzyme, or transporter in the conventional sense, azurin’s distinctive redox properties and selective tumor-targeting functions position it as a novel protein therapeutic candidate and biological tool for studying electron transfer and cancer biology[3][1][8]. No currently approved drugs directly target azurin, but derivative peptides are undergoing research for cancer therapy.

Other names
Blue copper proteinCupredoxinPaz (for mature Pseudomonas aeruginosa azurin)Bacterial azurin
02

Mechanism of action

Induces apoptosis in cancer cells (via interaction with p53 and cytochrome c), Interferes with cell signaling (by mimicking ephrinB2 ligand and inhibiting EphB2 receptor signaling), Electron transfer via copper redox cycle

03

Biological functions

Electron transport during respirationRedox reactions (electron transfer)Induction of apoptosisPotential modulation of host cell signaling
04

Disease associations

Cancer (anticancer activity)Infection (produced by pathogenic bacteria, but associated disease implication is as a potential therapy)
05

Safety considerations

Limited clinical safety data; theoretical concerns include immune response to bacterial proteinspotential off-target effects on normal mitochondria or redox stateand delivery challenges
06

Interacting drugs

None established as conventional small molecule drugs; however, peptide derivatives like p28 (from azurin), and experimental therapeutic conjugates are in research[3]
07

Biomarkers

p53 expression (for activity in cancer cells)Null for routine clinical biomarkers

Beyond the preview

Go deeper on Azurin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Azurin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call